Sigma Planning Corp Abbott Laboratories Transaction History

Sigma Planning Corp

$3.11 Billion
Q1 2024

A detailed history of Sigma Planning Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Sigma Planning Corp holds 57,001 shares of ABT stock, worth $5.88 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

57,001

Previous 46,185 23.42%

Holding current value

$5.88 Million

Previous $5.08 Million 27.44%

% of portfolio

0.21%

Previous 0.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $1.18 Million - $1.31 Million	10,816 Added 23.42%	57,001 $6.48 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $1.02 Million - $1.25 Million	-11,352 Reduced 19.73%	46,185 $5.08 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $3.45 Million - $4.14 Million	36,086 Added 168.23%	57,537 $5.57 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $559,631 - $623,546	-5,553 Reduced 20.56%	21,451 $2.34 Million
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $188,683 - $222,091	-1,948 Reduced 6.73%	27,004 $2.73 Million

Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $29,183 - $34,236	-307 Reduced 1.05%	28,952 $0
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $95,211 - $110,237	984 Added 3.48%	29,259 $2.83 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $91,046 - $110,046	-892 Reduced 3.06%	28,275 $3.07 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $1,254 - $1,529	-11 Reduced 0.04%	29,167 $3.45 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $157,351 - $192,668	-1,362 Reduced 4.46%	29,178 $4.11 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $64,746 - $71,628	-555 Reduced 1.78%	30,540 $3.61 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $170,956 - $201,240	-1,616 Reduced 4.94%	31,095 $3.61 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $165,763 - $195,294	1,523 Added 4.88%	32,711 $3.92 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $424,725 - $462,828	-4,045 Reduced 11.48%	31,188 $3.42 Million
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $274,828 - $333,758	2,999 Added 9.3%	35,233 $3.83 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $448,164 - $573,594	5,853 Added 22.19%	32,234 $2.95 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $122,875 - $179,678	-1,956 Reduced 6.9%	26,381 $2.08 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $296,846 - $330,459	-3,781 Reduced 11.77%	28,337 $2.46 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $51,231 - $55,551	626 Added 1.99%	32,118 $2.69 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $180,742 - $210,800	-2,480 Reduced 7.3%	31,492 $2.65 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $17,945 - $21,696	-271 Reduced 0.79%	33,972 $2.72 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $199,236 - $225,706	3,039 Added 9.74%	34,243 $2.48 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $56,127 - $67,711	923 Added 3.05%	31,204 $2.29 Million
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $6,275 - $6,925	109 Added 0.36%	30,281 $1.85 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $21,326 - $24,111	-379 Reduced 1.24%	30,172 $1.81 Million
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $68,656 - $73,504	1,279 Added 4.37%	30,551 $1.74 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $1.41 Million - $1.57 Million	29,272	29,272 $1.56 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Abbott Laboratories Transaction History